Almac Selected as a National Champion in the 2014/15 European Business Awards
Almac are delighted to be named as a National Champion in the “UKTI Award for Innovation” category in this year’s European Business Awards — a prestigious competition supported by businesses leaders, academics, media and political representatives from across Europe.
The annual award, sponsored by RSM International is now in its eighth year and, with 33 countries represented, is Europe’s largest and most significant cross-sector business recognition programme designed to promote excellence, best practice and innovation.
Alan Armstrong, CEO Almac commented: “We are very proud to be selected as a National Champion representing the UK for Innovation. The European Business Awards is widely recognised as the showcase for Europe’s most dynamic companies and we are delighted to have the opportunity to explain in more depth how we have achieved business success.”
Adrian Tripp, CEO of the European Business Awards said: “Congratulations to Almac, it is a great achievement to be named National Champion. The European Business Awards is going from strength to strength, inspiring businesses to greater success and helping to improve the competitive edge of companies across Europe.”
Jean Stephens, CEO of RSM International, said: “Every year these awards get tougher and more competitive as more companies, of varied sizes and across all sectors, choose to compete in this prestigious competition.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance